Search results
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 6 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Morningstar· 19 hours ago(Nasdaq:DRMA)(Nasdaq;DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions ...
Bryhali dosage: Form, strength, how to use, and more
Medical News Today· 6 days agoBryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcr
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Arcutis Biotherapeutics Inc (ARQT, Financial) reported strong revenue growth in Q1 2024, ...
Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results - Arcutis Biotherapeutics...
Benzinga· 2 days ago“Our strong performance in the first quarter, with the incredibly well-received launch of ZORYVE...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 1 day agoQ: What...partnership to enter the primary care setting for AD? A: Patrick Burnett indicated that discussions are progressing well, with a partnership likely to be finalized ...
It Took Me Years to Find the Right Psoriatic Arthritis Medication
Verywell Health via Yahoo News· 2 days agoAfter being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 6 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts
ETF DAILY NEWS· 13 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued to clients and investors on Tuesday ...